Eisai Patent For Aricept For Severe Alzheimer's Disease Extends To 2013
This article was originally published in PharmAsia News
Executive Summary
Japan's Supreme Court has rejected an appeal filed by generic drug makers, which effectively withheld a previous ruling to grant an extension to Eisai's Aricept (donepezil) for severe Alzheimer's disease until June 22, 2013